Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection: A Randomized Controlled Trial

NCT07165444 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07165444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07165444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection: A Randomized Controlled Trial
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2025
Completion date
February 1, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bismuth based quadruple therapy, helicobacter pylori infection, potassium-competitive acid blocker, proton pump inhibitor, treatment